ARID1A and cancer: In an analogy with HSP90, which buffers cryptic phenotypic variation at the protein level and whose loss promotes selection of favorable morphological traits during species evolution, it is conceivable that destabilization of the ERN in ARID1A-deficient cells may expose favorable, nonphysiological cellular states that can be selected during cancer evolution.